Keen Vision Acquisition Corp. 8-K

What Happened
Keen Vision Acquisition Corp. (KVAC) filed an 8-K reporting that shareholders approved amendments on January 22, 2026 to allow KVAC to extend its SPAC business combination period. The Investment Management Trust Agreement was amended (with Continental Stock Transfer & Trust Company) to permit up to two additional three‑month extensions—from January 27, 2026 up to July 27, 2026—by depositing $120,000 per three‑month extension into the trust account for all remaining public shares. KVAC deposited the initial $120,000 into the trust account, extending the deadline three months to April 27, 2026. On January 26, 2026 KVAC issued an unsecured promissory note for $120,000 to KVC Sponsor LLC (the Sponsor) to fund that deposit; the note bears no interest, matures on closing of a business combination, and is convertible into KVAC units at $10.00 per unit. KVAC also filed a fourth amended and restated memorandum and articles of association with the BVI Registry on January 26, 2026.

Key Details

• Annual Meeting: held January 22, 2026 (record date Dec 29, 2025); 8,297,973 of 9,238,421 shares (≈89.82%) were present or by proxy (quorum).
• Board elections: five nominees (Kenneth Ka Chun Wong, Alex Davidkhanian, Yibing Peter Ding, William Chu, Albert Cheung-Hoi Yu) elected; each received 7,294,186 votes “For” and 1,003,787 “Withheld.”
• Trust Amendment vote: 6,961,132 FOR / 1,336,841 AGAINST / 0 ABSTAIN. Charter (M&AA) amendment vote: same totals (6,961,132 FOR / 1,336,841 AGAINST).
• Redemptions: 3,781,900 shares were tendered for redemption at the Annual Meeting.
• Promissory Note: dated Jan 26, 2026, $120,000 principal to Sponsor, no interest, convertible into units at $10.00/unit, matures upon closing of a business combination.

Why It Matters
This filing gives KVAC additional time (up to two three‑month extensions) to complete a business combination, which can be important for finding and negotiating a target. The Sponsor funded the initial extension via a $120,000 promissory note rather than a cash infusion by the company, which preserves cash but could lead to future dilution if the note is converted into units. The substantial number of shares tendered for redemption (3,781,900) reduces the public float the Sponsor must fund for future extensions and could affect the pool of capital available for a deal. Investors should note the new timeline (extended to April 27, 2026 initially, with potential to extend to July 27, 2026) and the potential effects on timing, dilution, and redemption outcomes.